A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer

NCT00352690 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Safety of patients

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Paclitaxel poliglumex
DRUG: Carboplatin
RADIATION: External beam radiation therapy

Sponsor

Washington University School of Medicine

Collaborators

[object Object]